갑상선 유두암 재발의 예측 인자로서 혈중 호중구-림프구 비율의 임상적 유용성
Clinical Significance of Blood Neutrophil-to-Lymphocyte Ratio in Patients with Papillary Thyroid Carcinoma
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose: The neutrophil-to-lymphocyte ratio (NLR) is a strong predictor of poor prognosis in patients with various types of cancer. To date, the utility of NLR for prediction of prognosis in thyroid cancer patients has not been studied. Therefore, the aim of our study was to determine whether NLR is associated with other prognostic factors of papillary thyroid carcinoma and predictive of recurrence. Methods: We conducted a retrospective review of 367 patients who underwent thyroidectomy for papillary thyroid carcinoma from January 2005 to December 2007. We measured the white blood cell count including neutrophil and lymphocyte within one month preoperatively. The NLR was defined as the absolute neutrophil count divided by absolute lymphocyte count. Logistic regression analysis was applied for comparison of NLR with other prognostic factors, including tumor size, lymph node metastasis, multiplicity, extrathyroidal invasion, and TNM stage. We also determined the cut-off value of NLR with a prediction for recurrence. Results: Median age of patients was 47 years (16∼86 years) and the rate of papillary thyroid microcarcinoma was 65.7% (241/367 cases). Median follow-up period was 1,841 days (506∼3,135 days). The median value of NLR was 1.68 (0.66∼6.36). NLR was not related to any other prognostic factors of papillary thyroid carcinoma. The cut-off value of NLR for prediction of recurrence was 1.73, where the sensitivity was 66.7% and specificity was 69.8%. Conclusion: Patients with NLR equal to or higher than 1.73 showed significantly higher recurrence of papillary thyroid carcinoma. Further validation study should be conducted for clinical use of NLR as a prognostic marker.
Abstract
Purpose: The neutrophil-to-lymphocyte ratio (NLR) is a strong predictor of poor prognosis in patients with various types of cancer. To date, the utility of NLR for prediction of prognosis in thyroid cancer patients has not been studied. Therefore, the aim of our study was to determine whether NLR is associated with other prognostic factors of papillary thyroid carcinoma and predictive of recurrence. Methods: We conducted a retrospective review of 367 patients who underwent thyroidectomy for papillary thyroid carcinoma from January 2005 to December 2007. We measured the white blood cell count including neutrophil and lymphocyte within one month preoperatively. The NLR was defined as the absolute neutrophil count divided by absolute lymphocyte count. Logistic regression analysis was applied for comparison of NLR with other prognostic factors, including tumor size, lymph node metastasis, multiplicity, extrathyroidal invasion, and TNM stage. We also determined the cut-off value of NLR with a prediction for recurrence. Results: Median age of patients was 47 years (16∼86 years) and the rate of papillary thyroid microcarcinoma was 65.7% (241/367 cases). Median follow-up period was 1,841 days (506∼3,135 days). The median value of NLR was 1.68 (0.66∼6.36). NLR was not related to any other prognostic factors of papillary thyroid carcinoma. The cut-off value of NLR for prediction of recurrence was 1.73, where the sensitivity was 66.7% and specificity was 69.8%. Conclusion: Patients with NLR equal to or higher than 1.73 showed significantly higher recurrence of papillary thyroid carcinoma. Further validation study should be conducted for clinical use of NLR as a prognostic marker.
참고문헌 (29)
- Mazzaferri EL, "Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer", J Clin Endocrinol Metab, 86, pp.1447~1463 (2001)
- Schlumberger MJ, "Papillary and follicular thyroid carcinoma", N Engl J Med, 338, pp.297~306 (1998)
- Sherman SI, "Thyroid carcinoma", Lancet, 361, pp.501~511 (2003)
- Mazzaferri EL, "Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer", Am J Med, 97, pp.418~428 (1994)
- American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19, pp.1167~1214 (2009)
- Candido J, "Cancer-related inflammation", J Clin Immunol, 33(Suppl 1), pp.S79~S84 (2013)
- Del Prete A, "Molecular pathways in cancer-related inflammation", Biochem Med, 21, pp.264~275 (2011)
- Gomez D, "Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma", World J Surg, 32, pp.1757~1762 (2008)
- Gomez D, "Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma", J Surg Oncol, 97, pp.513~518 (2008)
- Walsh SR, "Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer", J Surg Oncol, 91, pp.181~184 (2005)
- Ohno Y, "Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma", J Urol, 184, pp.873~878 (2010)
- 노하니, "Usefulness of Pretreatment Neutrophil to Lymphocyte Ratio in Predicting Disease-Specific Survival in Breast Cancer Patients", Journal of Breast Cancer, 16(1), pp.55~59 (2013), 한국유방암학회[DOI]
- Hirashima M, "The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer", J Cancer Res Clin Oncol, 124, pp.329~334 (1998)
- Bhatti I, "Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil- lymphocyte versus platelet-lymphocyte ratio", Am J Surg, 200, pp.197~203 (2010)
- Sarraf KM, "Neutrophil", lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer, 2009, pp.137, 425~428
- Liu CL, "Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer", J Surg Oncol, 107, pp.493~497 (2013)
- 이가희, "대한갑상선학회 갑상선결절 및 암 진료 권고안 개정안", Endocrinology and Metabolism, 25(4), pp.270~297 (2010), 대한내분비학회
- Turak O, "Usefulness of neutrophil-to-lymphocyte ratio to predict inhospital outcomes in infective endocarditis", Can J Cardiol, 29, pp.1672~1678 (2013)
- Kahramanca S, "Neutrophil-to-lymphocyte ratio as a predictor of acute appendicitis", Ulus Travma Acil Cerrahi Derg, 20, pp.19~22 (2014)
- Tanındı A, "Neutrophil to lymphocyte ratio is associated with more extensive, severe and complex coronary artery disease and impaired myocardial perfusion", Turk Kardiyol Dern Ars, 42, pp.125~130 (2014)
- Lopez Hänninen E, "Interleukin-2based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients", J Urol, 155, pp.19~25 (1996)
- Tazzyman S, "Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth", Semin Cancer Biol, 23, pp.149~158 (2013)
- De Larco JE, "The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8", Clin Cancer Res, 10, pp.4895~4900 (2004)
- Niederhuber JE, "Cancer vaccines: the molecular basis for T cell killing of tumor cells", Oncologist, 2, pp.280~283 (1997)
- Fogar P, "Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome", Pancreas, 32, pp.22~28 (2006)
- Suzuki S, "Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system", Clin Exp Immunol, 110, pp.500~508 (1997)
- Balkwill F, "Inflammation and cancer: back to Virchow?", Lancet, 357, pp.539~545 (2001)
- Dallman PR, "Rudolph’s pediatrics", pp.1178~ (1977), Appleton-Century-Crofts
- Geaghan MS, "Hematology: basic principles and practice", pp.2733~ (2005), Elsevier Churchill Livingstone